Mario Sznol Selected Research

Mario Sznol Research Topics

Disease

97	Neoplasms (Cancer) 01/2024 - 01/2002
84	Melanoma (Melanoma, Malignant) 01/2024 - 01/2002
21	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2002
13	Neoplasm Metastasis (Metastasis) 11/2023 - 05/2012
11	Disease Progression 08/2023 - 04/2014
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2012
6	Fatigue 01/2021 - 05/2012
6	Brain Neoplasms (Brain Tumor) 01/2021 - 05/2012
6	Leukemia 01/2008 - 12/2003
4	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2002
3	Carcinoma (Carcinomatosis) 01/2024 - 10/2022
3	Uveal melanoma 10/2023 - 03/2015
3	Kidney Neoplasms (Kidney Cancer) 01/2021 - 07/2008
3	Nausea 01/2017 - 01/2002
3	Leukopenia 01/2017 - 09/2003
3	Colitis 07/2016 - 07/2006
3	Hyperbilirubinemia 07/2006 - 01/2002
2	Edema (Dropsy) 01/2021 - 01/2019
2	Pneumonia (Pneumonitis) 09/2019 - 07/2016
2	Exanthema (Rash) 09/2019 - 05/2012
2	Lymphoma (Lymphomas) 01/2018 - 01/2017
2	Anemia 01/2017 - 01/2002
2	Inflammation (Inflammations) 03/2016 - 05/2012
2	Diarrhea 10/2013 - 01/2002
2	Body Weight (Weight, Body) 07/2013 - 06/2012
2	Nevus (Nevi) 09/2009 - 06/2006
2	Hematologic Neoplasms (Hematological Malignancy) 09/2007 - 12/2003
2	Mucositis 07/2006 - 09/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2006 - 05/2004
2	Vomiting 09/2003 - 01/2002
1	Esophageal Neoplasms (Esophageal Cancer) 01/2024
1	Death (Near-Death Experience) 01/2024
1	Bites and Stings (Sting) 12/2023
1	Urologic Neoplasms (Urological Cancer) 10/2022

Drug/Important Bio-Agent (IBA)

35	NivolumabIBA 11/2023 - 07/2013
29	Immune Checkpoint InhibitorsIBA 01/2024 - 04/2014
23	IpilimumabIBA 11/2023 - 10/2011
15	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2009
14	AntibodiesIBA 01/2022 - 07/2005
9	bempegaldesleukinIBA 10/2023 - 01/2019
9	LigandsIBA 01/2022 - 06/2006
9	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 01/2017 - 09/2003
8	pembrolizumabIBA 01/2023 - 07/2016
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2006
8	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017 - 07/2003
7	Interleukin-2 (IL2)IBA 01/2023 - 07/2008
7	AntigensIBA 11/2020 - 09/2009
6	B7-H1 AntigenIBA 12/2021 - 01/2014
6	atezolizumabIBA 12/2021 - 01/2016
6	Monoclonal AntibodiesIBA 10/2019 - 10/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 09/2008
5	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2016
5	CTLA-4 AntigenIBA 01/2017 - 10/2011
4	InterferonsIBA 12/2023 - 12/2005
4	RNA (Ribonucleic Acid)IBA 11/2023 - 06/2011
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 12/2016
4	Programmed Cell Death 1 ReceptorIBA 01/2022 - 04/2012
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2018
4	CytokinesIBA 11/2020 - 04/2012
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 11/2014
3	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 01/2017
3	Alanine Transaminase (SGPT)IBA 01/2021 - 04/2015
3	Sunitinib (Sutent)FDA Link 01/2021 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 06/2015 - 11/2014
3	VemurafenibIBA 05/2013 - 04/2010
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2011 - 09/2009
3	laromustine (VNP40101M)IBA 11/2005 - 05/2004
3	Alkylating AgentsIBA 11/2005 - 05/2004
3	VNP 20009 (VNP20009)IBA 07/2005 - 01/2002
2	sotigalimabIBA 08/2023 - 01/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 09/2008
2	Interleukin-12 (IL 12)IBA 01/2023 - 12/2005
2	Lipase (Acid Lipase)FDA Link 01/2022 - 04/2015
2	Immunomodulating AgentsIBA 12/2021 - 04/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 05/2012
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2008
2	cyclopropapyrroloindoleIBA 01/2020 - 01/2019
2	Transaminases (Aminotransferases)IBA 09/2019 - 07/2016
2	src-Family KinasesIBA 03/2019 - 05/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 07/2016
2	trametinibIBA 01/2018 - 11/2014
2	VaccinesIBA 01/2018 - 10/2011
2	dabrafenibIBA 01/2018 - 11/2014
2	Immunoglobulin G (IgG)IBA 09/2017 - 04/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 05/2013
2	ElectrolytesIBA 01/2017 - 01/2017
2	ChitinasesIBA 02/2015 - 05/2012
2	Cytotoxins (Cytolysins)IBA 11/2014 - 01/2007
2	Carboplatin (JM8)FDA LinkGeneric 05/2013 - 01/2007
2	Phosphotransferases (Kinase)IBA 04/2010 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 12/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2006 - 11/2005
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Axitinib (AG 013736)IBA 01/2023
1	avelumabIBA 01/2023

Therapy/Procedure

67	Therapeutics 01/2024 - 07/2005
34	Immunotherapy 01/2024 - 12/2004
9	Drug Therapy (Chemotherapy) 10/2022 - 07/2003
4	Aftercare (After-Treatment) 02/2023 - 09/2003
2	Intravenous Infusions 12/2003 - 01/2002